NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-120-2020-2-US-02 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR
HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS 		US National Stage 18/013,042 Pending
NHGRI E-044-2013-1-MO-01 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA MO CN J/6735 Issued
NCI E-244-2015-0-CN-22 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use CN DIV 202211664625.9 Pending
NCATS E-026-2016-0-EA-01 Compounds for Improving MRNA Splicing EA DIV 202293446 Pending
NIDDK E-085-2022-0-PC-01 NEXT GENERATION TRANSPOSOSOMES PCT PCT PCT/US2022/082217 Expired
NCI E-210-2020-0-US-01 AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENT US National Stage 18/012,260 Pending
NIAID E-030-2023-0-US-01 Novel Compositions Of Matter Comprising Stabilized Pfs48/45 Proteins And Their Use US 63/476,897 Expired
NICHD E-037-2023-0-US-01 Single Source-Detector Separation Approach to Calculate Tissue Oxygen Saturation US 63/434,827 Expired
NIAID E-004-2023-0-US-01 EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES US 63/476,889 Expired
NCI E-152-2020-0-US-03 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD20 US National Stage 18/012,056 Pending
NCATS E-022-2022-0-PCT-02 METHODS AND SYSTEMS FOR ANALYZING TARGET ENGAGEMENT DATA
FROM BIOLOGICAL ASSAYS 		PCT PCT PCT/US2022/082171 Expired
NINDS E-201-2020-0-US-04 Nanobodies Directed to Coronavirus Spike Protein Receptor for Binding Domain and Uses Thereof US National Stage 18/011,767 Pending
NCATS E-136-2020-0-US-07 METHOTREXATE ANALOGS AND METHODS OF USE US National Stage 18/011,288 Pending
NIAID E-024-2023-0-US-01 MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION US 63/433,719 Expired
NCI E-033-2022-0-PCT-02 Mab 15B6 Blocks Mesothelin Shedding And Makes Very Active CAR-T Cell And BITE PCT PCT PCT/US2022/081766 Expired
NIAAA E-191-2021-0-PCT-02 SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE
HYDROLASE INHIBITORS 		PCT PCT PCT/US2022/052957 Expired
NCI E-038-2023-0-US-01 Discovery of small molecules targeting a noncanonical, hairpin-containing G-Quadruplex structure in MYCN Gene US 63/432,923 Abandoned
NICHD E-184-2021-0-PCT-02 LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO PCT PCT PCT/US2022/052704 Expired
NIDDK E-033-2023-0-US-01 Thyclotide Peptide Conjugates With Cell Permeability And Inhibitory Activity US 63/387,131 Expired
NCI E-113-2021-0-PCT-02 vBacteriophage Based-Vaccine System PCT PCT PCT/US2022/081383 Expired
NCI E-113-2021-0-CN-01 Bacteriophage Based-Vaccine System CN National Stage 202280082714.4 Pending
NIAID E-104-2020-0-IN-07 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS IN National Stage 202247071505 Pending
NCI E-078-2020-0-US-06 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM US National Stage 18/009,710 Pending
NICHD E-141-2019-0-US-07 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME US National Stage 18/009,571 Pending
NIAID E-104-2020-0-EP-06 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS EP National Stage 21729760.5 Pending
NIAID E-051-2023-0-US-01 HYDROGEL PURIFICATION OF CELL MATERIALS FOR PCR-ACTIVATED CELL SORTING US 63/386,745 Expired
NIAID E-240-2023-0-US-03 VACCINES AGAINST CORONAVIRUSES US 63/431,286 Expired
NIAAA E-190-2021-0-PCT-02 Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds PCT PCT PCT/US2022/081131 Expired
NEI E-071-2020-0-AU-04 COMPOUND EMBODIMENTS FOR TREATING RETINAL DEGENERATION AND METHOD EMBODIMENTS OF MAKING AND USING THE SAME AU National Stage 2021300425 Pending
NIAID E-150-2021-0-US-01 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST WESTERN, EASTERN, AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS (EVV) US 63/386,488 Expired
NIDA E-183-2021-0-US-02 PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION US ORD 18/076,071 Pending
NCI E-082-2023-0-EP-01 LIGANDS SPECIFIC FOR ASCT1 EP ORD 22306795.0 Pending
NEI E-028-2023-0-US-01 PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND USE FOR TREATING RETINAL
DEGENERATION 		US 63/430,251 Expired
NCATS E-169-2019-0-US-03 DIFFERENTIATION OF TROPHECTODERM LINEAGE CELLS FROM PLURIPOTENT STEM CELLS US National Stage 18/000,653 Pending
NCI E-142-2022-0-US-01 Topoisomerase Ill (TOP3) inhibitors as antiviral and anticancer compounds based on bisacridines US 63/429,923 Expired
NIAID E-080-2013-0-AU-10 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization AU DIV 2022279509 Pending
NIAID E-060-2015-0-AU-20 Novel Multivalent Nanoparticle-Based Vaccines AU DIV 2022279441 Pending
NIAID E-028-2024-0-US-01 Peptides And Peptide Micro Arrays For Detection And Differentiation Of Antibody Responses To Ebola Virus And Other Pathogens US 63/428,826 Expired
NCI E-219-2021-0-PCT-02 Identification Of And Cloning SBTCR_m807, A T Cell Receptor Targeting Kras G12V Mutation On HLA-A0301+ PCT PCT PCT/US2022/080650 Expired
NCI E-199-2021-0-PCT-02 COMPOSITIONS FOR INHIBITING DIPEPTIDE REPEAT PROTEIN-RIBOSOMAL RNA INTERACTION AND USES THEREOF PCT PCT PCT/US2022/051249 Expired
NCI E-062-2019-3-US-01 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US CON 18/059,840 Abandoned
NCI E-027-2022-0-US-01 TOPOISOMERASE Ill (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES US 63/428,529 Expired
NEI E-247-2020-0-US-02 BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTORS AND USE THEREOF US National Stage 18/000,008 Pending
NIAID E-143-2018-0-CA-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS CA National Stage 3185143 Pending
NCI E-265-2015-0-JP-36 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` JP DIV 2022-188263 Issued
NICHD E-039-2015-0-US-20 ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF US CON 18/058,457 Pending
NIAID E-228-2016-1-JP-16 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof JP DIV 2022-186724 Issued
NEI E-165-2017-0-US-05 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES US DIV 18/058,064 Pending
NIAID E-001-2024-0-US-04 Viral Strain Serology Assays US 63/384,673 Expired
NCI E-173-2018-2-JP-01 Viral Methods Of T Cell Therapy JP DIV 2022-185536 Pending